Abstract:Chromatin architecture governs DNA accessibility and gene expression. Thus, any perturbations to chromatin can significantly alter gene expression programs and promote disease. Prior studies demonstrate that every amino acid in a histone is functionally significant, and that even a single amino acid substitution can drive specific cancers. We previously observed that naturally occurring H2B variants are dysregulated during the epithelial to mesenchymal transition (EMT) in bronchial epithelial cells. Naturally occurring H2B variants differ from canonical H2B by only a few amino acids, yet single amino acid changes in other histone variants (e.g., H3.3) can drive cancer. We therefore hypothesized that H2B variants might function like oncohistones, and investigated how they modify chromatin architecture, dynamics, and function. We find that H2B variants are frequently dysregulated in many cancers, and correlate with patient prognosis. Despite high sequence similarity, mutations in each H2B variant tend to occur at specific "hotspots" in cancer. Some H2B variants cause tighter DNA wrapping around nucleosomes, leading to more compact chromatin structures and reduced transcription factor accessibility to nucleosomal DNA. They also altered genome-wide accessibility to oncogenic regulatory elements and genes, with concomitant changes in oncogenic gene expression programs. Although we did not observe changes in cell proliferation or migration in vitro, our Gene Ontology (GO) analyses of ATAC-seq peaks and RNA-seq data indicated significant changes in oncogenic pathways. These findings suggest that H2B variants may influence early-stage, cancer-associated regulatory mechanisms, potentially setting the stage for oncogenesis later on. Thus, H2B variant expression could serve as an early cancer biomarker, and H2B variants might be novel therapeutic targets.

Phosphorylation of Histone H2B Serine 32 Is Linked to Cell Transformation

Data from Ribosomal S6 Kinase 2 is a Key Regulator in Tumor Promoter–Induced Cell Transformation

Persistent Phosphorylation at Specific H3 Serine Residues Involved in Chemical Carcinogen‐induced Cell Transformation

Supplementary Figure 2 from Phosphorylation of H2AX at Ser139 and a New Phosphorylation Site Ser16 by RSK2 Decreases H2AX Ubiquitination and Inhibits Cell Transformation

Phosphorylation of Histone H3 Serine 28 Modulates Rna Polymerase Iii-Dependent Transcription

Histone H3 phospho-regulation by KimH3 in both interphase and mitosis

Histone H2A Phosphorylation Recruits Topoisomerase IIα to Centromeres to Safeguard Genomic Stability

The Cytoplasmic Deacetylase HDAC6 is Required for Efficient Oncogenic Tumorigenesis

Cyclin-dependent Kinase 1-Mediated Phosphorylation of SET at Serine 7 is Essential for Its Oncogenic Activity

Regulation of Hsf4b Nuclear Translocation and Transcription Activity by Phosphorylation at Threonine 472.

Global Histone Modification Profiling Reveals the Epigenomic Dynamics During Malignant Transformation in a Four-Stage Breast Cancer Model

Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor.

The Role of Glycogen Synthase Kinase 3β in the Transformation of Epidermal Cells

The Role Of Glycogen Synthase Kinase 3 Beta In The Transformation Of Epidermal Cells

Aberrant expression of histone H2B variants reshape chromatin and alter oncogenic gene expression programs

Ubp-M Serine 552 Phosphorylation By Cyclin-Dependent Kinase 1 Regulates Cell Cycle Progression

RSK2-mediated cGAS phosphorylation induces cGAS chromatin-incorporation-mediated cell transformation and cancer cell colony growth

PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis

Growth factor–induced activation of MSK2 leads to phosphorylation of H3K9me2S10 and corresponding changes in gene expression

RSK2 as a key regulator in human skin cancer.

Phosphorylation of Jhd2 by the Ras-cAMP-PKA(Tpk2) pathway regulates histone modifications and autophagy